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Variants in the host genome may 
inhibit tumour growth in devil facial 
tumours: evidence from genome-
wide association
Belinda Wright1, Cali E. Willet1,2, Rodrigo Hamede3, Menna Jones3, Katherine Belov1 & Claire 
M. Wade  1
Devil facial tumour disease (DFTD) has decimated wild populations of Tasmanian devils (Sarcophilus 
harrisii) due to its ability to avoid immune detection and pass from host to host by biting. A small 
number of devils have been observed to spontaneously recover from the disease which is otherwise 
fatal. We have sequenced the genomes of these rare cases and compared them to the genomes of devils 
who succumbed to the disease. Genome-wide association, based on this limited sampling, highlighted 
two key genomic regions potentially associated with ability to survive DFTD. Following targeted 
genotyping in additional samples, both of these loci remain significantly different between cases and 
controls, with the PAX3 locus retaining significance at the 0.001 level, though genome-wide significance 
was not achieved. We propose that PAX3 may be involved in a regulatory pathway that influences the 
slowing of tumour growth and may allow more time for an immune response to be mounted in animals 
with regressed tumours. This provides an intriguing hypothesis for further research and could provide a 
novel route of treatment for this devastating disease.
The Tasmanian devil (Sarcophilus harrisii), a carnivorous marsupial native to Australia, is threatened with extinc-
tion in the wild due to devil facial tumour disease (DFTD). DFTD is a rare form of transmissible cancer that was 
first officially observed in 1996 in the north-east of Tasmania1. The tumour is transmitted as an allograft by biting 
during social interactions2, 3. As DFTD arose once in a north-eastern devil and then spread throughout the popu-
lation, it is unusual in that the tumour genome has a different origin to that of its host. Since its emergence, DFTD 
has rapidly spread throughout all but the far-western populations of devils with infection rates of up to 95%4. 
This high infection rate is in part due to the ability of the tumour to evade immune detection by down-regulating 
the major histocompatibility complex (MHC)5. Tumours usually develop on the face and metastasise to distal 
organs, resulting in organ failure and death6, 7. Examination of the tumour transcriptome has indicated a Schwann 
cell origin – a cell of the peripheral nerve with a neural crest precursor8. There is now evidence of evolution 
in response to DFTD with allele frequency changes over time following disease-mediated sweeps in wild devil 
populations9.
In one wild north-western Tasmanian population, West Pencil Pine (WPP)10, it has been observed that some 
devils have spontaneously cleared the cancer. These individuals were confirmed to have DFTD when first sam-
pled, yet tumours were recorded to have shrunk or disappeared on subsequent sampling11. There are no apparent 
differences in MHC profiles within this population relating to DFTD infection12. Some devils from this popula-
tion have demonstrated serum antibodies against DFTD11. The underlying cause of this rare immune response 
remains unclear. Our hypothesis is that variants within the genomes of these particular devils may confer some 
resistance to DFTD progression or metastasis.
To investigate this we compared the genomes of seven devils that survived DFTD infection or displayed evi-
dence of tumour regression to six young control devils that succumbed to the disease. Young control devils were 
used to account for potential effects of immunological senescence increasing susceptibility to infection. Through 
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comparisons with the Tasmanian devil reference genome13, we discovered variable sites across the genomes of 
these samples. We next employed a genome-wide association to identify genomic regions that segregate different 
haplotypes between young, DFTD-infected devils and devils with regressed tumours from the WPP population. 
Three candidate loci were further targeted in additional controls from the same population. We present two key 
regions of the genome that may contribute to the observed tumour regression in these devils.
Results/Discussion
Genome-wide association (GWAS) analysis revealed a large region spanning 1.6 megabases (Mb) on chromo-
some 3. The region contains 38 single nucleotide polymorphisms (SNPs) that fall within the top 100 loci from 
association after filtering on quality, seven of which map within introns of the PAX3 gene (best p value = 0.00007; 
Table 1, also Table S1). A second associated region on chromosome 6 spans 830 kilobases (kb). This region con-
tains 17 SNPs within the top 100 associated loci after filtering and eight of these map to intronic sequence of the 
TLL1 gene (best p value = 0.00022; Table 1, also Table S1). No SNPs affecting coding sequence were found within 
the associated regions in the genomes of the sampled devils.
A single SNP in the region of the NBAS gene on chromosome 1 obtained the lowest p value from the GWAS 
(p = 0.00006, Table 1). This SNP along with 2 SNPs from each segregating haplotype at the PAX3 and TLL1 loci 
were targeted in an additional 13 control samples from WPP and one additional regressed devil from this popu-
lation. The significant association at the NBAS locus disappeared following addition of further samples (Table 2). 
The significant associations at both TLL1 and PAX3 were retained following addition of further samples though 
was somewhat diminished especially for the TLL1 locus (Table 2).
Scaffold
Scaffold 
Size (Mb)
No. of SNPs 
(In top 100)
Best 
p-value INDELs Nearest Candidate Genes
Chr1_0002 1.08 97 (2) 0.00039 189 MKI67
Chr1_0216 3.85 203 (1) 0.00094 443 RBL1
Chr1_0248 0.97 102 (1) 0.00049 217 CHRNA4
Chr1_0256 4.38 410 (1) 0.00094 1047 DOK5
Chr1_0386 0.71 136 (1) 0.00006 173 NBAS, DDX1
Chr2_0233 4.02 222 (2) 0.00045 562 YWHAZ
Chr2_0238 0.81 274 (1) 0.00094 411 EBAG9
Chr2_0398 3.39 419 (4) 0.00045 945 UNC13B
Chr3_0006 0.94 14 (1) 0.00067 74 SEPT2
Chr3_0048 2.23 96 (1) 0.00131 328 CD96
Chr3_0369 3.06 146 (2) 0.00028 451 STK11IP, INHA, OBSL1
Chr3_0388 4.28 407 (38) 0.00007 1496 PAX3, EPHA4
Chr3_0519 0.60 23 (1) 0.00028 55 PAX3 (pseudogene)
Chr4_0035 2.57 132 (2) 0.00028 342 RASAL2, BRINP2
Chr4_0110 2.19 106 (2) 0.00094 338 NGFR, PHB
Chr5_0005 1.75 41 (1) 0.00049 146 CERK
Chr5_0006 2.48 292 (1) 0.00067 636 FAM19A5
Chr5_0069 4.66 224 (2) 0.00131 971 BTBD11
Chr6_0050 4.00 131 (1) 0.00094 655 MAPK10, ARHGAP24
Chr6_0079/80 0.12 12 (0)* 0.00165 69 SPOCK3
Chr6_0081 1.17 161 (17) 0.00022 480 TLL1
Table 1. Summary of loci segregating with DFTD regression identified by GWAS. Key candidate genes for 
DFTD regression are in bold. *Included as scaffolds contains annotations for neighbouring genes of TLL1 
(identified by GWAS) and corresponding to a syntenic block as identified by comparison with human, mouse 
and opossum.
Locus SNP
GWAS Targeted loci
Chi-square p-value Chi-square p-value
NBAS 377874_T 16.34 0.00005*** 0.9441 0.33120
PAX3 2290941_C 13.48 0.00024** 10.94 0.00094**
PAX3 2253019_T 16.34 0.00006*** 15.48 0.00008***
TLL1 476140_C 11.8 0.00059** 5.44 0.01968*
TLL1 635881_C 11.8 0.00059** 5.347 0.02076*
Table 2. Results from association analysis in targeted SNPs (N = 27) as compared to results obtained from 
genome-wide association (N = 13). *Significant at 0.05; **Significant at 0.001; ***Significant at 0.0001. See 
Supplementary Material, Table S1 for a full distribution of genotypes for cases and controls.
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PAX3 and TLL1 share a common physiological pathway. Both are involved in angiogenesis through regulation 
of intermediate targets, known as bone morphogenic proteins (BMPs). BMPs stimulate angiogenesis through 
activation of vascular endothelial growth factor (VEGF) in both normal development and cancer metastases14–16. 
In our regressed samples we have investigated the host genomes rather than the tumour genome, so variants 
identified here in PAX3 and TLL1 would be expected to play a role in the tumour microenvironment rather than 
the tumour itself. PAX3 expression has been implicated in a number of cancers including neuroblastoma and may 
enhance oncogenic potential through regulating the expression of a suite of other genes17.
It is possible that variants of PAX3 and TLL1 affect angiogenesis in DFTD. PAX3 is also believed to directly 
regulate FLT1, a VEGF receptor18, 19. If the process of angiogenesis is disrupted by variants of PAX3 and/or 
TLL1, then tumour metastasis and growth may be hindered as it has no access to the blood supply and nutrients 
required for growth. This may allow the infected individual more time to mount an immune response to the 
disease. This serves as a potential mode of action for the regression of tumours observed in devils in this study.
There may be alternative modes of action whereby PAX3 and TLL1 influence the tumour microenvironment 
and impact tumour progression. It remains unclear whether PAX3 and TLL1 activity is triggered by DFTD infec-
tion in regressed cases. PAX3’s involvement in a number of other cancers makes it a particularly intriguing target 
for further research. We cannot rule out the possibility that other candidate genes identified in the GWAS play a 
role in tumour regression, or that tumour lineage may be an influencing factor.
Confirmation of these results is not possible from the current dataset, however results from targeted genotyp-
ing increase confidence in the involvement of the PAX3 locus in tumour regression. Assessment of the expression 
of BMP and FLT (VEGF) in tissues surrounding tumours during tumour progression would enable us to under-
stand their role in angiogenesis in DFTD. However, such samples are currently unavailable and would be very 
difficult to source in the field as regressing tumours are rare and sequential access to tumour and host biopsies 
over the time points needed for analysis is not feasible. We cannot rule out the possibility that tumour regression 
is not under genetic control. Taken together with recent research identifying a genetic response to DFTD infec-
tion at a population level9, along with identification of an immune response to DFTD in some devils in the WPP 
population11, there is mounting evidence that genetics plays a role in resistance to DFTD. The current study is 
preliminary in nature and we have here identified two regions worthy of further investigation and proposed a 
potential mode of action whereby these loci could influence tumour progression.
Conclusion
Disruption of angiogenesis to developing tumours that slows growth and metastasis serves as a plausible model 
for DFTD regression in seven Tasmanian devils. Slowing of tumour growth rate may allow more time for an 
infected individual to mount an immune response. Tumour regression is expected to be a complex trait and many 
other factors and genes may be involved in this rare ability. Future work should aim to identify the frequency of 
this phenotype in the wild. Given the small number of animals that have recovered from the disease, it is likely to 
be very rare. However, the frequency may increase over time due to strong selection pressure from the disease. 
Confirmation of the involvement of PAX3 in DFTD regression may lead to novel treatments for this devastating 
disease.
Materials and Methods
Samples. We have sequenced the genomes of 12 devils from WPP – six of these (five females, one male) were 
individuals with regressed tumours that survived in the wild disease-free for some time (Table 3). Five devils (two 
females, three males) who had succumbed to DFTD at a young age were selected as controls. One female sample 
was discarded from the genome-wide association analysis as infection status was ambiguous, although genomic 
data from this sample was utilised for identification of variants. Devil samples for whole genome sequencing 
were collected in the field from WPP with approval from the University of Tasmania’s Animal Ethics Committee 
(A0010296 and A0013326) and from the Tasmanian Department of Primary Industries and Water (TFA15214, 
TFA08211, TFA14228, TFA13924). All methods were performed according to the relevant guidelines and reg-
ulations. In addition, we have utilised genome sequences from a previous study (GenBank: GCA_000219685.1, 
ref. 20). These two animals consist of a south-eastern male devil who succumbed to DFTD at a young age and a 
north-western male devil who survived a vaccination trial though eventually succumbed when re-infected in a 
laboratory trial.
Sequencing and variant discovery. Tissue (ear biopsy) was obtained and DNA extracted using a 
phenol-chloroform extraction method21. The 12 Tasmanian devil genomes were sequenced by the Ramaciotti 
Centre for Genomics at the University of New South Wales, Kensington, with 100 base pair (bp) paired-end librar-
ies using Truseq library preparation kits on an Illumina HiSeq 2000. An initial seven samples were sequenced 
in a separate lane each with another five samples sequenced across three lanes. The average read depth coverage 
was 10–15 times. Genome sequences were deposited in the European Nucleotide Archive (accession numbers: 
ERS682204-ERS682210; ERS1202857-ERS1202861). Re-sequenced genomes were aligned to the Tasmanian devil 
reference genome assembly version 7.0, (GenBank: GCA_000189315.1, ref. 13) using Burrows-Wheeler Aligner 
version 0.6.222 with default parameters for paired-end data.
SNPs and INDELs. Polymorphic sites across the entire genome were identified using SAMtools mpileup 
version 0.1.1923, including only bases and reads with minimum base and mapping quality scores of 20, respec-
tively. Pileup was generated at all sites to allow homozygous reference genotypes to be included in the dataset if 
at least one sample displayed a non-reference allele after quality filtering. PCR duplicates were removed using 
SAMtools and local realignment around insertions and deletions was performed using GATK IndelRealigner 
version 2.724. Insertions and deletions (INDELs) were detected using SAMtools23 with a coefficient of 50 based on 
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a phred-scaled probability score used to scale down mapping quality of reads containing multiple mismatches. 
Variant call format files (.vcf) for individual animals were merged and filtered to retain individual locus calls with 
quality scores greater than 20.
Genome-wide association. Using custom perl scripts, the SNP vcf files were filtered and re-formatted 
into transposed PED (tped) format to be compatible with association analysis with PLINK version 1.0725 and 
Haploview version 4.226. SNPs where the root mean squared mapping quality at the site was less than 20 were 
excluded. For inclusion in the tped, genotypes were required to be covered by at least four high quality reads, with 
at least two reads or 20% of covering reads (whichever was greater) supporting the non-reference allele in order 
to call a heterozygous SNP. To minimize calling SNPs in duplicated loci, genotype calls were only accepted where 
read depth was less than 2.5 times the average mapped read depth. Variant sites were filtered for a minor allele 
frequency of 12% (to require an allele that is seen in at least two separate samples – i.e. 26 potential alleles from 13 
samples, 3/26 = 11.5) and genotyping fail rate of <1%.
An adjusted standard genome-wide association (GWAS) in PLINK25 was applied to variant SNPs across the 
genome. The −log10 transformed probabilities arising from the individual locus Chi-squared tests were plotted 
across chromosomes using Haploview26 to visualise regional significance of allele frequency differences between 
cases (regressed devils) and controls (non-regressed devils). Due to the large number of loci in the analysis rela-
tive to the numbers of cases and controls, a second association analysis pruned the variant sites for local linkage 
disequilibrium (LD) using PLINK25. This removed SNPs in 50 bp windows where loci had LD of greater than 0.8.
Mutation detection. Within regions of association, the available genome annotation information was com-
bined with SNP and INDEL variants detected in our sample set. Annotated genes in devil as well as the pre-
dicted locations of genes in devil based on the human and mouse genomes were obtained from the University 
of California Santa Cruz Genome Browser (http://genome.ucsc.edu/; refs 27 and 28) and corresponding protein 
sequences were downloaded from Ensembl release 82 (www.ensembl.org; ref. 29). With these, predictions on the 
functional consequences of variants were made. The concordances of genomic locations of SNPs and INDELS 
with coding regions or untranslated regions were recorded. Next, their potential to change protein sequence 
(SNPs only) was assessed by translating the sequence with and without the variant in relation to the known 
reading frame of the protein. SNPs in conserved regions were identified from comparisons with 33 placental 
mammals using phastCons and phylop30, 31 and converted to devil coordinates using liftOver27.
Associated reference scaffolds arising from the GWAS were investigated further. At this time the Tasmanian 
devil reference genome v7.013 does not have scaffolds that have been fully ordered and oriented. Instead, the 
reference genome comprises 35,974 scaffold sequences presumptively mapped to six autosomes and an X chro-
mosome. We cannot conclusively identify all of the candidate genes in an associated region. To compensate for 
the lack of reference contiguity, significant SNPs occurring on smaller scaffolds with annotated genes were fur-
ther examined by assessing synteny within more complete reference genomes including human (hg38)32, mouse 
(GRCm38)33 and opossum (monDom5)34 for potentially neighbouring genes.
Stratification and relatedness. Relatedness among samples was assessed by calculating the pair-wise 
identity by descent using PLINK25 to identify any underlying stratification that may influence the analysis. We 
Infection status Sex Y.O.B.
Age 1st 
infected Diagnostic criteria Comments
Regressed F 2006 5 Visual inspection
Survived in the 
wild until age 5 
DFTD free
Regressed F 2006 5 Visual inspection
Survived in the 
wild until age 6 
DFTD free
Regressed F 2008 3 Histopathology/cytology Tumour regressed for ~6 months
Regressed F 2009 3 Visual inspection Tumour regressed for ~2 years
Regressed F 2006 3 Histopathology/cytology Tumour regressed for ~6 months
Regressed M 2009 3 Cytology
Survived in wild 
until age 7 DFTD 
free
DFTD-infected M 2011 18 mths Histopathology/cytology Succumbed
DFTD-infected F 2011 15 mths Histopathology/cytology Succumbed
DFTD-infected M 2010 18 mths Histopathology/cytology Succumbed
DFTD-infected F 2011 18 mths Histopathology/cytology Succumbed
DFTD-infected F 2010 15 mths Histopathology/cytology Succumbed
Table 3. Details of 11 West Pencil Pine samples used in the genome-wide association study. Nb. When a 
tumour is detected within the mouth on sampling then no biopsy or fine needle aspiration is possible therefore 
visual inspection scores are used to assign infection status. As sampling took place at 3 month intervals, periods 
of tumour regression and survival are approximate. Y.O.B. – year of birth. Ages at first infection are given in 
years except for those given in months (mths).
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employed multi-dimensional scaling to visualise the two main principal components explaining the genotypic 
variation among our samples to test for obvious stratification between the case and control groups. A small sam-
ple size and high relatedness estimates amongst our samples impacted the power to detect a genomic signal. For 
this reason we chose to investigate those 100 most significant SNPs from the GWAS as this method has previously 
been used to successfully map a causative mutation in a genome-wide association study35.
Targeted genotyping in additional samples. Primers were designed to target SNPs in the three key 
regions identified from the GWAS (Table S2). An additional 13 control devils from WPP who succumbed to 
DFTD with no apparent host response to infection were genotyped at these SNPs to identify whether the signif-
icance of the association between cases and controls was sustained for these loci (Table S3). One additional devil 
with confirmed regression of DFTD was also included (Table S3). Targeted SNPs were amplified by PCR using 
a HotStarTaq Plus DNA Polymerase kit (Qiagen) under the following conditions: 2 uL dNTPs (10 mM), 10 uL 
PCR buffer (10x), 2 uL forward and reverse primers (10 mM), 0.5 uL taq polymerase (5 U) per reaction using PCR 
cycling times of 95°C for 5 min initial denaturation, followed by 35 cycles of 94°C for 1 min, 58°C for 1 min, 72°C 
for 1 min and a final extension of 72°C for 10 min. Resulting PCR product was subjected to Sanger sequencing 
at the Australian Genome Research Facility, Westmead, NSW, Australia. Sequences were analysed using MEGA 
v6.0636 to determine individual genotypes. A second association test was conducted in PLINK on a locus by locus 
basis for the five targeted SNPs including both the new samples and the original 13 samples used in the GWAS.
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